Back to Search
MEGAN ORLANDO, MD
MD
Obstetrics & Gynecology Physician
NPI: 1861815151IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
35.138709(OH)DR.0068460(CO)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 2016
Research & Publications (20)
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer.
PMID 10761752·Ann Oncol·2000
4-observational
Pressure study of monoclinic ReO2 up to 1.2 GPa using X-ray absorption spectroscopy and X-ray diffraction.
PMID 19096174·J Synchrotron Radiat·2009
8-other
A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
PMID 18829514·Clin Cancer Res·2008
3-trial
Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells.
PMID 17960360·Diabetologia·2008
8-other
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium.
PMID 18096563·Hum Reprod·2008
8-other
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer.
PMID 17588704·Lung Cancer·2007
3-trial
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
PMID 17602086·J Clin Oncol·2007
3-trial
Ghrelin in vitro modulates vasoactive factors in human umbilical vein endothelial cells.
PMID 17408626·Fertil Steril·2007
4-observational
Are prisoner characteristics associated with therapeutic community treatment process?
PMID 17497550·Am J Drug Alcohol Abuse·2007
8-other
Ghrelin affects the release of luteolytic and luteotropic factors in human luteal cells.
PMID 17535999·J Clin Endocrinol Metab·2007
8-other
Development and validation of a test battery to assess subtle neurodevelopmental differences in children.
PMID 16716399·Neurotoxicology·2006
8-other
Affective and behavioral responses to health-related social control.
PMID 17100500·Health Psychol·2006
8-other
The dimensions of change in therapeutic community treatment instrument.
PMID 16594821·Psychol Assess·2006
8-other
Regulation of vascular endothelial growth factor synthesis and release by human luteal cells in vitro.
PMID 16595603·J Clin Endocrinol Metab·2006
8-other
Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur.
PMID 16283346·Arch Dermatol Res·2006
8-other
Dynamic effects among patients' treatment needs, beliefs, and utilization: a prospective study of adolescents in drug treatment.
PMID 16033496·Health Serv Res·2005
4-observational
A cross-lagged model of psychiatric problems and health-related quality of life among a national sample of HIV-positive adults.
PMID 15626930·Med Care·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1635 AURORA CT FL 3
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1861815151
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile